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Abstract
The HLA region is considered to be the main genetic risk factor for rheumatoid arthritis. Previous
research demonstrated that HLA-DRB1 alleles encoding the shared epitope are specific for disease
that is characterized by antibodies to cyclic citrullinated peptides (anti-CCP). In the present study,
we incorporated the shared epitope and either anti-CCP antibodies or rheumatoid factor into
linkage disequilibrium mapping, to assess the association between the shared epitope or antibodies
with the disease gene identified. Incorporating the covariates into the association mapping provides
a mechanism 1) to evaluate gene-gene and gene-environment interactions and 2) to dissect the
pathways underlying disease induction/progress in quantitative antibodies.
Background
Rheumatoid arthritis (RA) represents a complex disease in
which genes and environmental factors interplay to
manifest the symptoms of this condition. Despite the
phenotypic heterogeneity involved in this disease, the
genetic contribution to RA is estimated to be 50-60% [1],
and the HLA region has the largest influence on genetic
risk. Gregersen et al. [2] showed that HLA-DRB1 alleles
encoding a common amino-acid sequence (the shared
epitope (SE)) in the third hypervariable region of the DRB1
molecule have been identified as risk alleles for RA. The
functional significance implied by the location of this SE
sequence has stimulated efforts to search for the putative
RA antigen [3]. In addition, because most RA patients have
autoantibody responses, including rheumatoid factor (RF,
a measurement of the reactive IgM antibodies) and cyclic
citrullinated peptides (anti-CCPs), Huizinga et al. [3]
compared the HLA profile in a healthy population and
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antibodies, demonstrating strong interactions between the
SE and anti-CCP antibodies. Based on these findings, we
incorporated the number of SE alleles (categorized by NN,
SN, and SS for 0, 1, and 2 SE alleles, respectively) and anti-
CCP or RF into our association mapping to search for the
disease locus and to assess the associations between SE,
antibodies, and the disease gene in a region of 6p21
(previously identified in our linkage analyses). Two
dummy variables, NN and SN, were created; SS was been
treated as the reference group (NN = 1 if NN, 0 otherwise;
SN = 1 if SN, 0 otherwise). Incorporating this association
profile allows us to investigate associations between the
disease locus and the covariates, and will help to elucidate
etiopathologies between different phenotypes and the
disease genes.
Recently, Liang and Chiu [4] proposed a robust multipoint
association mapping approach using case-control data.
This approach provides an estimate of the genetic effect
and the location of the disease locus τ, along with sampling
uncertainty to help investigators narrow down chromoso-
mal regions that putatively harbor a disease gene (τ). The
genetic effect denoted by “C” characterizes the excess
disease allele frequency among cases compared to controls.
Chiu et al. [5] extended this method to estimate C by
incorporating covariates into the mapping, in order to
estimate τ more efficiently. The covariates could be either
quantitative or qualitative. Hence, we incorporated anti-
CCP or IgM RF as well as the number of SE alleles into our
association mapping to estimate the disease locus for RA
and to assess interactions between the disease gene and the
covariates simultaneously [6].
Methods
Materials
A total of 868 cases and 1194 controls in the North
American Rheumatoid Arthritis Consortium study
(NARAC) were included in analyses. We used PLINK
[7,8] to clean the data, excluding two cases and one
control from the data set due to their genome-wide
heterozygosity <30%. We also checked the call rate,
cryptic relatedness, and multidimensional scaling. No
additional subjects were excluded.
From the total 35,574 single-nucleotide polymorphisms
(SNPs) available originally, we excluded the SNPs with
a call rate <90% or MAF (minor allele frequency) <0.05,
and those that failed the Hardy-Weinberg equilibrium
test (p < 0.05) as measured by the PLINK software. A
total of 29,616 SNPs remained for further gene mapping.
The 29,616 SNPs were used to make plots for the average
excess target allele frequency in cases compared to
controls, divided by the estimated magnitude of linkage
disequilibrium (LD) (as shown on page 146 in Chiu
et al.) [5]. A region harboring 2732 SNPs with higher
peaks between 28 and 40 cM was identified. A total of
1561 SNPs ranging from about 28,000 to 40,000 kb,
with blocks defined by r
2 > 0.7, was selected as tag SNPs
using Haploview software. We converted base pair (bp)
into centimorgan (cM) approximately by dividing bp by
10
6. Hence, our analyses focused on 706 cases with RF,
anti-CCP, and number of SEs and 1191 controls with
number of SEs.
Association approaches
The method hinges on the following expression [4,5]:
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including the following notations:
D Cases
D Controls
t An arbitrary location in the study region
τ Disease locus
gs s
DD (,) : A vector of functions of covariates for cases
(s
D)a n dc o n t r o l s(s
D )
C Genetic effect at τ
dt LD between t and τ (assuming it is independent of
covariates)
Yt
D =1 If the case carries the high-risk allele from his/her
father
Yt
D = 0 If the case does not carry the high-risk allele from
his/her father
Xt
D =1 If the case carries the high-risk allele from his/
her mother
Xt
D = 0 If the case does not carry the high-risk allele from
his/her mother
Similarly, one can define the indicator variables, Yt
D
and Xt
D , for controls accordingly.
In an unmatched case-control design, all possible
combinations of case-control pairs were used to localize
the disease locus in this approach, a covariate for each
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etc.]. In this study, the covariates of antibodies
were available in cases only; hence, we defined
gS S S
DD D (,) = . We can show that the approach remains
legitimate and the property in the Appendix in Chiu
et al. [5] still holds true (unpublished data). For the
covariate available in both cases and controls,
gS S S S
DD D D (,) =−, in the present study.
The genetic effect C, quantified by the excess high-risk
allele frequency among cases compared to controls at the
disease locus τ, can then be modeled as a function of the
covariates through logistic regression [6] as follows:
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The regression coefficients b
T characterize the associations
between the genetic effect at τ and the covariates. For
covariates available for cases and controls, the approach
from Chiu et al. [5] was directly applicable. On the other
hand, incorporating covariates into LD mapping can
improve the efficiency in estimating τ when the covariate
carries additional information on the association under
study. Because this method represents an extension of the
approach proposed by Liang and Chiu [4] that is based on
the generalized estimating equation approach, it is also
robust, given that no assumption about the genetic
mechanism is required, other than that the region contains
no more than one susceptibility locus for the qualitative
trait while incorporating multiple markers into the analysis
simultaneously. No assumption about the underlying
genetic mechanism of an incorporated quantitative covari-
ate is required either.
The LD mapping was conducted through the sliding
window approach, in which sequential analyses were
performed for every 100 SNPs. We examined the associa-
tions between the estimated disease locus and the
covariates in the case-control study. In addition, we
compared the results from incorporating the covariates
with those from the original search, where no covariates
were incorporated. This allowed us to evaluate the
improvement in efficiency provided by the additional
information from the given covariates. To make a
comparison with other association analyses, we also
performed individual SNPs analysis using the chi-square
test in PLINK.
Results
Figure 1 illustrates the average excess target allele
frequency in cases compared to controls divided by the
estimated magnitude of LD [4,5] for all SNPs located
between 28,000 and 40,000 kb on 6p21. Several local
peaks appeared in this region, the global peak being
located within the region of 32,500-33,000 kb. Theore-
tically, the SNPs in high LD with τ or at τ should have a
higher excess of the target allele (presumably the high-
risk allele) among cases compared to controls than other
SNPs in the region. Figure 1 provides an illustration of
approximately where the peak (the location of τ)m a yb e
and whether the one-disease-locus assumption is reason-
able. The results with and without incorporating
covariates from the 706 cases and 1191 controls are
displayed in Tables 1, 2, 3. Several local peaks were
identified in this region with and without incorporating
covariates (data not shown). The global peak for the
estimate of τ was located at 32.623 cM (95% CI =
[32.6191, 32.6264]): it had the highest estimated C
value of 0.9, along with a p-value less than 10
-15 for
testing C = 0 (the absence of association). The estimated
location happened to be the locus of HLA-DRB1 gene,
indicating that this gene is strongly associated with
disease risk (i.e., it might be the disease gene or is in
strong LD with the disease gene (Table 1). In the single-
SNP analysis (Figure 2), 251 out of 1561 SNPs had a
p-value ≤ 3.20 × 10
-5 (the significance level was chosen
after applying the Bonferroni correction for multiple
tests). The most significant SNP appeared to be the SNP
rs660895 at 32.685360 cM (p- v a l u e=1 . 4 2×1 0
-107), as
displayed in Table 4. The number of SE alleles is
significantly associated with the estimated disease
locus, with both p-values for SN and NN less than
10
-15. There was, however, no evidence that the genetic
effect at this location was associated with RF or anti-CCP
levels. We also assessed the interaction between the SE
numbers and the estimated disease locus by testing
whether b2 (the regression coefficient for SN) = b3 (the
regression coefficient for NN) (Tables 2, 3). The
interactions were very significant for the estimated
disease locus at 32.6 cM, revealing that these loci have
interactions with SE alleles. In addition to the quantita-
tive covariate, we also incorporated two dummy
variables reflecting male-male and male-female case-
control pairs, respectively, into the mapping. We also
tested whether there was gene-sex interaction. The results
suggested that there was no sex effect, or sex-gene
interaction in our analyses (data not presented).
Discussion
Based on Figure 1 and the analysis results, the one-
disease-locus assumption seems to be reasonable for the
data in this region. Because results from previous studies
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CCP and SE [4], we examined the linear relationship
between anti-CCP and the number of SE alleles in the
706 cases using a linear regression model. Our results
suggested that the anti-CCP levels were significantly
d i f f e r e n tw h e nc o m p a r i n gc a s e sw i t h1a n d2S Ea l l e l e s
(p = 0.0050), but were not significantly different when
c o m p a r i n gc a s e sw i t h0a n d2S Ea l l e l e s( p = 0.85).
Figure 1
The average excess target allele frequency in cases compared to controls divided by the estimated magnitude
of LD for all SNPs located between 28,000-40,000 kp on 6p21. Green “X”, the estimated disease locus, green bracket
indicates the 95% confidence interval for the disease locus.
Table 1: Association mapping without a covariate based on 706
cases and 1191 controls
τ (cM) C
Estimate 32.622789 0.900
SE 0.001864 0.0480
Z 18.752
p-value <1.0 × 10
-15
Table 2: Association mapping with covariates RF, SN, and NN based on 706 cases and 1191 controls
τ (cM) C b1 (RF) b2 (SN) b3 (NN) Testing H0: b2 = b3
Estimate 32.619281 0.518 0.00790 -1.643 -2.981
SE 0.002099 0.0301 0.0898 0.138
Z 0.262 -18.300 -21.572 16.430
p-value 0.793 <1.0 × 10
-15 <1.0 × 10
-15 <1.0 × 10
-15
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SE from the association mapping, anti-CCP remained
insignificant (p = 0.98). Similarly, excluding the two
dummy variables for SE from the association mapping
yielded an insignificant association with RF (p = 0.63).
These results suggested that the association between anti-
CCP or RF and the estimated disease locus was not
significantly dependent on the number of SE alleles.
Additionally, the estimate of the disease locus was quite
consistent with the result from the association analysis of
individual SNPs, based on a chi-square test. The
Marshfield genetic map for this region (6p22.1-6p21.2)
is 44.41-54.76 cM, spanning 10.35 cM, while by dividing
by 10
6, our map is 28 cM-44 cM, spanning 12 cM. The
distances between markers will affect the results; how-
ever, because the SNP data are very dense, after
converting the distances into recombination fractions,
the difference resulting from two maps is likely to be
v e r yl i m i t e d .T h ee x a c ti m p a c to ft h i sc o n s i d e r a t i o n
warrants future exploration.
Conclusion
We applied a robust multipoint LD mapping approach
to locate disease genes for RA with incorporation of
Table 3: Association mapping with covariates anti-CCP, SN, and NN based on 706 cases and 1191 controls
τ C b1 (anti-CCP) b2 (SN) b3 (NN) Testing H0: b2 = b3
Estimate 32.618194 0.507 -0.0315 -1.533 -2.837
S.E. 0.002109 0.0267 0.0842 0.130
Z -1.183 -18.217 -21.831 16.572
p-value 0.237 <1.0 × 10
-15 <1.0 × 10
-15 <1.0 × 10
-15
Figure 2
p-Values for individual SNPs from the association analysis based on the chi-square test.
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were associated with the covariates. Our results suggest
that the disease loci in the region of 6p21 were strongly
associated with the SE alleles. The efficiency in estimat-
ing the disease genes remained similar when incorporat-
ing RF or anti-CCP into the mapping, revealing that
these two quantitative covariates did not provide
additional information on the disease locus localization.
Through this application, we demonstrated that while
performing multipoint fine mapping, this approach not
only facilitates examination of gene-gene interactions
and gene-covariate interactions, but also helps to
elucidate the pathways of complex diseases.
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Table 4: Association analysis of individual SNPs with a p- v a l u e<1 . 0×1 0
-30
SNP Base pair Minor
a allele MAF in cases MAF in controls Chi-square statistic p-Value OR
rs6910071 32,390,830 G 0.5212 0.1952 435.6 1.00 × 10
-96 4.488
rs9268368 32,441,930 G 0.6163 0.397 170.7 5.33 × 10
-39 2.44
rs3129941 32,445,660 A 0.09517 0.2496 135.8 2.20 × 10
-31 0.3163
rs2395157 32,456,120 G 0.5339 0.2767 247.4 9.41 × 10
-56 2.994
rs3117098 32,466,490 G 0.1374 0.306 137 1.23 × 10
-31 0.3612
rs2076530 32,471,790 A 0.2826 0.5553 265.5 1.08 × 10
-59 0.3154
rs6932542 32,488,240 A 0.2144 0.4719 249.5 3.33 × 10
-56 0.3054
rs9268615 32,510,870 A 0.5928 0.3774 165.7 6.56 × 10
-38 2.401
rs2395173 32,512,840 A 0.1433 0.3466 185.4 3.23 × 10
-42 0.3152
rs3129882 32,517,510 G 0.1955 0.4261 209.9 1.43 × 10
-47 0.3273
rs7192 32,519,620 A 0.1643 0.3916 215.2 1.00 × 10
-48 0.3055
rs6903608 32,536,260 G 0.1007 0.3116 220 8.99 × 10
-50 0.2475
rs2516049 32,678,380 G 0.583 0.3059 279.9 8.02 × 10
-63 3.172
rs660895
b 32,685,360 G 0.5382 0.1927 485.4 1.42 ×1 0
-107 4.884
rs5000634 32,771,540 G 0.61 0.3827 183 1.10 × 10
-41 2.523
rs6457617 32,771,830 G 0.1861 0.491 343.6 1.03 × 10
-76 0.2371
rs9275312 32,773,710 G 0.2953 0.1213 177.2 1.97 × 10
-40 3.035
rs9275388 32,777,060 G 0.4942 0.2412 249.3 3.64 × 10
-56 3.074
rs2858305 32,778,440 C 0.1551 0.3749 206.7 7.19 × 10
-47 0.3061
rs7745656 32,788,950 A 0.1084 0.289 166.2 5.02 × 10
-38 0.2992
aMinor allele based on the whole sample.
bBold font indicates the most significant SNP in this region.
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